Impact of stigma on clinician training for opioid use disorder care: a qualitative study in a primary care learning collaborative

H Klusaritz, A Bilger, E Paterson… - The Annals of Family …, 2023 - Annals Family Med
PURPOSE We undertook a study to examine how stigma influences the uptake of training
on medication for opioid use disorder (MOUD) in primary care academic programs …

Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina

SM Oros, LM Christon, KS Barth… - … of Psychiatry in …, 2021 - journals.sagepub.com
Objective Utilization of medications for opioid use disorder (MOUD) has not been widely
adopted by primary care providers. This study sought to identify interprofessional barriers …

Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare

MK McCurry, S Avery‐Desmarais… - Journal of Nursing …, 2023 - Wiley Online Library
Introduction Healthcare professionals, particularly nurses, have negative attitudes towards
individuals with opioid use disorder (OUD) and these attitudes can contribute to suboptimal …

“I think we're getting better but we're still not there”: Provider-based stigma and perceived barriers to care for people who use opioids (PWUO)

K McLean, J Murphy, N Kruis - Journal of Substance Use and Addiction …, 2024 - Elsevier
Background Despite significant efforts to improve access to medications for opioid use
disorder (MOUD), uptake remains low relative to the scope of the problem in the United …

[HTML][HTML] A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians

SA Hooker, AL Crain, AB LaFrance, S Kane… - Addiction Science & …, 2023 - Springer
Background Many primary care clinicians (PCCs) hold stigma toward people with opioid use
disorder (OUD), which may be a barrier to care. Few interventions exist to address PCC …

Models of resident physician training in opioid use disorders

R Graddy, AJ Accurso, DR Nandiwada… - Current Addiction …, 2019 - Springer
Abstract Purpose of Review Medications for addiction treatment (MAT) are the standard of
care for treating opioid use disorder (OUD) and reducing overdose deaths, yet demand for …

[HTML][HTML] Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone

A Carl, E Pasman, MJ Broman, JJ Lister, E Agius… - Drug and Alcohol …, 2023 - Elsevier
Abstract Background Medications for Opioid Use Disorder (MOUD) are efficacious, however
only one-third of individuals with an opioid use disorder (OUD) enter into treatment. Low …

[HTML][HTML] Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

A Jakubowski, S Singh-Tan, K Torres-Lockhart… - Addiction Science & …, 2023 - Springer
Background Hospital-based clinicians infrequently initiate medications for opioid use
disorder (MOUD) for hospitalized patients. Our objective was to understand hospital-based …

Opioid use-related stigma and health care decision-making.

RL Brown, E Batty, M Lofwall, M Kiviniemi… - Psychology of …, 2023 - psycnet.apa.org
Objective: Stigma is described as highly relevant to the treatment context for opioid use
disorder (OUD) partly because it is known to influence providers' treatment decisions and …

Attitudes toward medication for opioid use disorder among substance use treatment providers

E Pasman, G Lee, R Kollin, B Rodriguez… - Substance Use & …, 2022 - Taylor & Francis
Background: Provider attitudes can be a powerful reinforcer of stigma toward medication for
opioid use disorder (MOUD). This study examines attitudes toward MOUD among substance …